Natural Product: NPC473531

Natural Product IDNPC473531
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
[(2S,3R,4R,5S,6R)-4,5-Diacetyloxy-6-[[9-(1,3-Benzodioxol-5-Yl)-6,7-Dimethoxy-1-Oxo-3H-Benzo[F][2]Benzofuran-4-Yl]Oxy]-2-Methyloxan-3-Yl] Acetate
IUPAC Name [(2S,3R,4R,5S,6R)-4,5-diacetyloxy-6-[[9-(1,3-benzodioxol-5-yl)-6,7-dimethoxy-1-oxo-3H-benzo[f][2]benzofuran-4-yl]oxy]-2-methyloxan-3-yl] acetate
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL444750
PubChem CID 11285224
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0001392] Lignans, neolignans and related compounds
      • [CHEMONTID:0001511] Lignan glycosides

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey BWGZOLFCSSJAKB-SNNYXJDNSA-N
Standard InCHI InChI=1S/C33H32O14/c1-14-28(44-15(2)34)30(45-16(3)35)31(46-17(4)36)33(43-14)47-29-20-11-24(39-6)23(38-5)10-19(20)26(27-21(29)12-40-32(27)37)18-7-8-22-25(9-18)42-13-41-22/h7-11,14,28,30-31,33H,12-13H2,1-6H3/t14-,28+,30+,31-,33+/m0/s1
SMILES CC1C(C(C(C(O1)OC2=C3COC(=O)C3=C(C4=CC(=C(C=C42)OC)OC)C5=CC6=C(C=C5)OCO6)OC(=O)C)OC(=O)C)OC(=O)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   652.18 Volume:   619.411
?
Van der Waals volume.
Dense:   1.053 LogP:   3.138
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.038
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.021
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   11.0 Rigid Bonds:   35.0
TPSA:   160.58
?
Topological Polar Surface Area.
H-Bond Acceptor:   14.0
H-Bond Donor:   0.0 Rings:   6.0
Heavy Atoms:   14.0

MedChem Properties

QED Drug-Likeness Score:   0.255 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.369 Fsp3:   0.394
MCE-18:   125.565
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.553 Fluc inhibitor:   0.007
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.753
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.333
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.118 Promiscuous compounds:   0.198

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.937 MDCK Permeability:   -4.595
Pgp-inhibitor:   0.952 Pgp-substrate:   0.799
PAMPA:   0.905
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.337
20% Bioavailability (F20%):   0.471 30% Bioavailability (F30%):   0.072
50% Bioavailability (F50%):   0.992

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.001 MRP1:   0.983
Plasma Protein Binding (PPB):   97.128% Volume Distribution (VD):   -0.207
Fu: 3.541%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.937
OATP1B3 inhibitor:   0.996 BCRP inhibitor:   0.151
BSEP inhibitor:   1.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.157 CYP1A2-substrate:   0.108
CYP2C19-inhibitor:   0.984 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.001 CYP2C9-substrate:   1.0
CYP2D6-inhibitor:   0.01 CYP2D6-substrate:   0.895
CYP3A4-inhibitor:   0.122 CYP3A4-substrate:   0.057
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.996
HLM stability:   0.819
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  1.827 Half-life (T1/2):  1.331

ADMET: Toxicity

hERG Blockers:  0.098 hERG Blockers (10um):  0.472
Human Hepatotoxicity (H-HT):  0.888 Drug-induced Liver Injury (DILI):  0.995
AMES Toxicity:  0.94 Rat Oral Acute Toxicity:  0.644
Maximum Recommended Daily Dose:  0.892 Skin Sensitization:  0.969
Carcinogencity:  0.925 Eye Corrosion:  0.0
Eye Irritation:  0.003 Respiratory Toxicity:  0.044
Drug-induced Neurotoxicity:  0.722 Ototoxicity:  0.895
Hematotoxicity:  0.936 Drug-induced Nephrotoxicity:  0.914
Genotoxicity:  0.99 RPMI-8226 Immunitoxicity:  0.285
A549 Cytotoxicity:  0.327 Hek293 Cytotoxicity:  0.723
BCF:   0.993
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.845
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.089
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.217
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO20590 Justicia patentiflora Species Acanthaceae Eukaryota n.a. Vietnamese n.a. PMID[15921419]
NPO20590 Justicia patentiflora Species Acanthaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO20590 Justicia patentiflora Species Acanthaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell line KB Homo sapiens IC50 = 20.0 nM PMID[7525959]
NPT83 Cell line MCF7 Homo sapiens IC50 = 45.0 nM PMID[26026364]
NPT393 Cell line HCT-116 Homo sapiens IC50 = 35.0 nM PMID[11520227]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC473531 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8125 Intermediate Similarity NPC471923
0.8095 Intermediate Similarity NPC473697
0.7176 Intermediate Similarity NPC292712
0.6944 Remote Similarity NPC239113
0.686 Remote Similarity NPC471921
0.6782 Remote Similarity NPC471922
0.6712 Remote Similarity NPC19600
0.6706 Remote Similarity NPC114550
0.6706 Remote Similarity NPC312006
0.6706 Remote Similarity NPC602979
0.6705 Remote Similarity NPC471920
0.6471 Remote Similarity NPC474075
0.6471 Remote Similarity NPC483381
0.6437 Remote Similarity NPC129930
0.6437 Remote Similarity NPC20114
0.6421 Remote Similarity NPC275690
0.6395 Remote Similarity NPC184624
0.6267 Remote Similarity NPC115123
0.6263 Remote Similarity NPC161609
0.6211 Remote Similarity NPC35266
0.6211 Remote Similarity NPC167045
0.6211 Remote Similarity NPC114120
0.5769 Remote Similarity NPC78944
0.557 Remote Similarity NPC15212
0.5413 Remote Similarity NPC286301
0.5413 Remote Similarity NPC313063
0.5122 Remote Similarity NPC22130
0.5062 Remote Similarity NPC299820

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC473531 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data